Detalles de la búsqueda
1.
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
Breast Cancer Res Treat
; 203(2): 351-363, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37878152
2.
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients.
Pharmacol Res
; 163: 105241, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33049397
3.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330065
4.
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.
Breast Cancer Res Treat
; 181(1): 199-209, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32246377
5.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30536609
6.
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients.
Breast Cancer Res Treat
; 178(1): 57-62, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31346846
7.
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
Breast Cancer Res Treat
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38592543
8.
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.
J Cell Physiol
; 232(6): 1571-1578, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27861874
9.
Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
Clin Breast Cancer
; 22(4): 308-318, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980541
10.
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation.
Acta Haematol
; 126(1): 13-20, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21411985
11.
Impact of HIV infection on baseline characteristics and survival of women with breast cancer.
AIDS
; 35(4): 605-618, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33394680
12.
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer.
Gynecol Oncol Rep
; 38: 100880, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34926761
13.
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy.
J Natl Cancer Inst
; 113(4): 462-470, 2021 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750143
14.
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Clin Cancer Res
; 27(12): 3443-3455, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785482
15.
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor.
Blood
; 112(7): 2990-5, 2008 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18492955
16.
Metronomic chemotherapy combined with endocrine therapy: are we challenging some dogmas?
Expert Rev Anticancer Ther
; 20(7): 563-573, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32536212
17.
Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials.
ESMO Open
; 5(1)2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32079624
18.
Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study.
ESMO Open
; 5(5): e000876, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33051191
19.
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
Clin Breast Cancer
; 20(1): e89-e98, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31378534
20.
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer.
Front Oncol
; 9: 547, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31297336